Assistant Professor @PKU1898 | PHD '18 @JohnsHopkinsSPH | MS '13 @DukeGHI | Sexual & Reproductive Health and Rights | Human Behavior. Views=Mine

Beijing
Excited to share this call for papers for a special issue that I am editing with two colleagues, focusing on Reproductive Health! Please consider submitting a manuscript and share this call to anyone who might be interested! 🤓 link.springer.com/journal/42…
1
65
Africa: protests & riots Data: @ACLEDINFO & @Mapbox
4
42
141
13,087
Can I now claim expertise about Cuffing Season (i.e.,seasonality in looking for romantic/sexual partners)?! In all seriousness, glad I could contribute to this informative podcast! (Also, seems like there’s evidence for cuffing season based on activity in online dating apps)
PFRH's @alisongemmill guests on the latest episode of @voxdotcom's Explain It to Me podcast, providing scientific context to help answer the question: Is Cuffing Season real? Snuggle up and listen now: podcasts.apple.com/us/podcas…
2
3
8
1,312
1
139
#APACC2025 #AsiaPacific in Japan next year! Excellent opportunity to contribute to HIV research and discussion in the Asia-Pacific region. Abstract submission Deadline: 7 March 2025, 23:59 JST. Submit Here: amededu.co/3A40Cj5 @Academic_MedEdu
2
4
2,014
Fan Yang retweeted
Prof Cath Mercer discussing data from NATSAL (UK) and how the COVID pandemic pivoted its delivery and use. #IUSTI2024 @ASHMMedia
1
2
178
Key findings from @ICW_Global & @UNAIDS confronting coercion report, all happening within the last year of coercive practices across 23 countries hearing from over 25,000 women
4
6
303
Don't miss doctoral candidate Ying (Sally) Zhang's poster on a global review of national guidelines of post-exposure prophylaxis for the prevention of HIV, presented by @DrJasonJOng, today at #AIDS2024 and online. @MonashSTM @MonashResearch @Alfred_Research
3
6
221
Fan Yang retweeted
In the PURPOSE 1 randomized, controlled trial involving women in South Africa & Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection. Full trial results: nej.md/3zRElVj #AIDS2024
6
115
211
72,955
📊 Today at #AIDS2024, Past IAS President @LindaGailBekker presents full results from PURPOSE 1 trial. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women. Read IAS President & AIDS 2024 Int'l Co-Chair @ProfSharonLewin's statement.
1
40
99
5,281
Interesting question was asked during Q&A about Doxy's use for malaria prevention as well. Potential double kill? #AIDS2024
Side effects and fear of stigma were common barriers to doxyPEP use in Kenya. #AIDS2024
1
72
Fan Yang retweeted
We need better peer reviewers for scientific journals. So glad to see this workshop on building capacity and investing in people. Room14a. #AIDS2024
2
7
265
Fan Yang retweeted
Some promising results of DoxyPrEP use in female sex workers in Japan. #AIDS2024
11
22
14,792
Share your exciting research with us! Call for abstract by Mar the 22nd for the upcoming #APACC2024 in Hong Kong! Deadline: Friday, 22 March 2024 at 23:59 HKT Submission Portal: virology.eventsair.com/apacc… Website: academicmedicaleducation.com…
1
60
Apply now for a scholarship to attend the APACC 2023, Asian Stigma & Discrimination Forum, and HIV Cascade of Care. Deadline: 30 April 2023. @annettesohnBKK @IHRIOfficial Details>> bit.ly/43ynnG5
9
11
963
📣 @jiasociety is publishing a new supplement in 2024 on “Implementation research and the #HIV response” and is looking for abstracts. ✅ Learn more now and submit your abstract by 15 May! bit.ly/3Zb5dY2
17
21
2,303
Showcase your incredible work in HIV/sexual health at #APACC2023, whether it be research, practice, or community engagement! Late-breaker submission will open soon on April 3. Both structured abstracts ("research") and descriptive abstracts ("lessons learned") are welcome!
#APACC2023 is proud to be an #IAS2023 Affiliated Independent Event. Late-breaker abstract submission opens soon – don’t miss out on the opportunity to present your research to leading experts. Learn more >> bit.ly/3YQD8EK #HIV #Hepatitis #Tuberculosis #ImpSci #COVID19
2
4
542